Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Arvinas Inc.

www.arvinas.com

Latest From Arvinas Inc.

Eisai Joins PROTAC Club Through New Oncology Collab

Japanese firm joins increasing global interest in PROTAC approach to cancer as it links with UK university for drug discovery collaboration.

Cancer Platform Technologies

Deal Watch: Vertex Expands Gene-Editing Efforts With A Pair Of Deals

CF-focused Vertex will buy Exonics and expand a collaboration with CRISPR Therapeutics, with plans to develop therapies for DMD and myotonic dystrophy type 1. Merck acquires TGFβ-focused Tilos, while Achaogen offloads most of its assets at auction.

Deals Business Strategies

Bayer Pays Arvinas $50m To Form Protein Degrader R&D Pact

The partnership gives the German major another potential source of drugs to treat cardiovascular, oncological and gynecological diseases.

Deals Companies

Few Signs Of An IPO Slowdown Despite US Biotech Stock Slump

Biotech stock valuations wavered in October with the average IPO return in the US nearing negative territory, but observers say there is still a healthy market for new biopharma offerings in 2018 and into next year.

Business Strategies Financing
See All

Company Information

  • Industry
  • Biotechnology
    • Large Molecule
  • Pharmaceuticals
  • Therapeutic Areas
  • Cancer
  • Neurology, Nervous System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Arvinas Inc.
  • Senior Management
  • John Houston, PhD, Pres. & CEO
    Sean Cassidy, CFO
    Ian Taylor, PhD, CSO
    Matthew Batters, VP, Bus. Dev. & Counsel
    Ronald Peck, MD, CMO
  • Contact Info
  • Arvinas Inc.
    Phone: (203) 535-1456
    395 Winchester Ave.
    5 Science Pk.
    New Haven, CT 06511
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register